Growing community of inventors

Rehovot, Israel

Noga Yerushalmi

Average Co-Inventor Count = 2.70

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 37

Noga YerushalmiC Frank Bennett (6 patents)Noga YerushalmiEric G Marcusson (6 patents)Noga YerushalmiChristine Esau (6 patents)Noga YerushalmiAyelet Chajut (6 patents)Noga YerushalmiDan Peer (2 patents)Noga YerushalmiRimona Margalit (2 patents)Noga YerushalmiIlia Rivkin (2 patents)Noga YerushalmiEsther Meiri (1 patent)Noga YerushalmiChristine Esau (1 patent)Noga YerushalmiAyelet Chajut (1 patent)Noga YerushalmiGilad Shlomit (0 patent)Noga YerushalmiNoga Yerushalmi (10 patents)C Frank BennettC Frank Bennett (201 patents)Eric G MarcussonEric G Marcusson (31 patents)Christine EsauChristine Esau (14 patents)Ayelet ChajutAyelet Chajut (8 patents)Dan PeerDan Peer (20 patents)Rimona MargalitRimona Margalit (11 patents)Ilia RivkinIlia Rivkin (2 patents)Esther MeiriEsther Meiri (1 patent)Christine EsauChristine Esau (2 patents)Ayelet ChajutAyelet Chajut (1 patent)Gilad ShlomitGilad Shlomit (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Rosetta Genomics Ltd. (8 from 64 patents)

2. Regulus Therapeutics Inc. (6 from 61 patents)

3. Tel Aviv University (2 from 810 patents)


10 patents:

1. 10301627 - Targeting microRNAs for the treatment of liver cancer

2. 9845470 - Targeting microRNAS for the treatment of liver cancer

3. 9506062 - Targeting microRNAs for the treatment of liver cancer

4. 9487781 - Compositions and methods for treatment of ovarian cancer

5. 9150857 - Targeting microRNAs for the treatment of liver cancer

6. 8883757 - Compositions and methods for treatment of ovarian cancer

7. 8680067 - Targeting microRNAs for the treatment of liver cancer

8. 8501237 - Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostics and therapy

9. 8211867 - Targeting microRNAs for the treatment of liver cancer

10. 8178129 - Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostic and therapy

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/16/2025
Loading…